Sienna Biopharmaceuticals, the innovative dermatology-focused company, has raised $12M in Series A funding led by Partner Fund Management (PFM) and ARCH Venture Partners with participation from Two River. The company has raised $46M over their 2 rounds of funding.
Page 3 of 4